TRIM22 and cancer: TRIM22 protein was examined in 126 cases of NSCLC cancer specimens and 15 cases of normal lung tissue specimens using immunohistochemistry.In normal lung tissues, we observed weak/negative TRIM22 staining in normal bronchial epithelial cells and alveolar cells (Figure 1A–1B).